Jean Donadieu

Active 1993–2025

128
Papers
18,600
Citations
76
h-index
123
i10-index

Citations

Citations per year for Jean Donadieu1986: 1 citations1994: 1 citations1995: 2 citations1996: 7 citations1997: 15 citations1998: 11 citations1999: 9 citations2000: 10 citations2001: 9 citations2002: 15 citations2003: 8 citations2004: 8 citations2005: 23 citations2006: 23 citations2007: 28 citations2008: 41 citations2009: 39 citations2010: 53 citations2011: 50 citations2012: 95 citations2013: 105 citations2014: 176 citations2015: 180 citations2016: 124 citations2017: 226 citations2018: 158 citations2019: 546 citations2020: 651 citations2021: 645 citations2022: 354 citations2023: 274 citations2024: 565 citations2025: 234 citations2026: 2 citations1987–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,204 citing papers, 23.4% of this breakdownFrance: 439 citing papers, 8.5% of this breakdownGermany: 350 citing papers, 6.8% of this breakdownItaly: 333 citing papers, 6.5% of this breakdownUnited Kingdom: 295 citing papers, 5.7% of this breakdownChina: 220 citing papers, 4.3% of this breakdownNetherlands: 191 citing papers, 3.7% of this breakdownCanada: 175 citing papers, 3.4% of this breakdownSpain: 146 citing papers, 2.8% of this breakdownSweden: 144 citing papers, 2.8% of this breakdownAustralia: 122 citing papers, 2.4% of this breakdownJapan: 117 citing papers, 2.3% of this breakdown
0%23.4%Other 27.4%

Fields

  • Medicine49.9%
  • Immunology and Microbiology27.5%
  • Biochemistry, Genetics and Molecular Biology20.3%
  • Neuroscience0.8%
  • Nursing0.3%
  • Materials Science0.2%
  • Other1%

Topics

  • Immunodeficiency and Autoimmune Disorders7%
  • Histiocytic Disorders and Treatments6.1%
  • Blood disorders and treatments4.8%
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms3.5%
  • Immune Cell Function and Interaction3.3%
  • Parvovirus B19 Infection Studies2.4%
  • Other72.9%

Coauthors

All papers

Open in search
  1. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Blood 2016 cited by 1,561

  2. The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew R. Gennery, Sofia Grigoriadou, Steven M. Holland, Gritta Janka, Maria Kanariou, Christoph Klein, Helen J. Lachmann, Desa Lilić, Ania Manson, N. Pascual Martínez, Isabelle Meyts, Nicolette Moes, Despina Moshous, Bénédicte Neven, Hans D. Ochs, Capucine Pïcard, Ellen D. Renner, Frédéric Rieux‐Laucat, Reinhard Seger, Annarosa Soresina, Dominique Stoppa‐Lyonnet, Vojtěch Thon, Adrian J. Thrasher, Frank L. van de Veerdonk, Anna Villa, Corry M.R. Weemaes, Klaus Warnatz, Beata M. Wolska, Shen-Yin Zhang - The Journal of Allergy and Clinical Immunology In Practice 2019 cited by 621

  3. B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , J. Magarian Blander, Claire‐Michèle Farber, Guido Silvestri, Charlotte Cunningham‐Rundles, Michaela Calvillo, Carlo Dufour, Lucia Dora Notarangelo, Vassilios Lougaris, Alessandro Plebani, Jean‐Laurent Casanova, Stephanie Ganal, Andreas Diefenbach, Juan I. Aróstegui, Manel Juan, Jordi Yagüe, Nizar Mahlaoui, Jean Donadieu, Kang Chen, Andrea Cerutti - Nature Immunology 2011 cited by 721

  4. Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Siraj M. Ali, Samuel Briggs, Omotayo Fasan, Jared Block, Sébastien Héritier, Jean Donadieu, David B. Solit, David M. Hyman, José Baselga, Filip Jankú, Barry S. Taylor, Christopher Y. Park, Zahir Amoura, Ahmet Doǧan, Jean‐François Emile, Neal Rosen, Tanja A. Grüber, Omar Abdel‐Wahab - Cancer Discovery 2015 cited by 533

  5. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Blood 2012 cited by 693

  6. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease

    Authors: , , , , , , , , , , , , , , , , , - Blood 2018 cited by 624

  7. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marco Gessi, Gianpiero Tamburrini, Sébastien Héritier, Jean Donadieu, Jacinthe Bonneau‐Lagacherie, Claire Lamaison, Laure Farnault, Sylvie Fraitag, Marie‐Laure Jullié, Julien Haroche, Matthew Collin, Jackie Allotey, Majid Madni, Kerry Turner, Susan Picton, Pasquale Barbaro, Alysa Poulin, Ingrid S. Tam, Dina El Demellawy, Brianna Empringham, James A. Whitlock, Aditya Raghunathan, Amy A. Swanson, Mariko Suchi, Jon M. Brandt, Nabeel R. Yaseen, Joanna Weinstein, İrem Eldem, Bryan A. Sisk, Vaishnavi Sridhar, Mandy Atkinson, Lucas R. Massoth, Jason L. Hornick, Sanda Alexandrescu, Kee Kiat Yeo, Kseniya Petrova‐Drus, Stephen Peeke, Laura Muñoz-Arcos, Daniel Leino, David D. Grier, Robert B. Lorsbach, Somak Roy, Ashish R. Kumar, Shipra Garg, Nishant Tiwari, Kristian T. Schafernak, M M Henry, Astrid G. S. van Halteren, Oussama Abla, Eli L. Diamond, Jean‐François Emile - Blood 2021 cited by 155

  8. BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marion Gillibert‐Yvert, Jean‐Louis Stéphan, Fleur Cohen‐Aubart, Julien Haroche, Isabelle Pellier, Frédéric Millot, Brigitte Lescoeur, Virginie Gandemer, Christine Bodemer, Roger Lacave, Zofia Hélias‐Rodzewicz, Valérie Taly, Frédéric Geissmann, Jean Donadieu - Journal of Clinical Oncology 2016 cited by 335

  9. Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study)

    Authors: , , , , , , , , , , , - Blood 2017 cited by 206

  10. Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Houda Boudiaf, Andrej Lissat, Karel Švojgr, Fanette Bernard, Sarah Elitzur, Michal Golan, D. A. Evseev, Michael Maschan, Ahmed Idbaïh, Olga Slater, Milen Minkov, Valérie Taly, Matthew Collin, Jean‐Claude Alvarez, Jean‐François Emile, Sébastien Héritier - Journal of Clinical Oncology 2019 cited by 220

  11. Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis

    Authors: , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2012 cited by 232

  12. The ouroboros of autoimmunity

    Authors: , , , , , - Nature Immunology 2024 cited by 39

  13. Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Louis‐Jean Couderc, Gérard Couillault, Virginie Courteille, Elodie Curlier, Geneviève de Saint Basile, François Deméocq, Nathalie de Vergnes, Catherine Devoldère, Anne Deville, Jean Donadieu, Éric Doré, Fabienne Dulieu, I. Durieu, C. Edan, Natacha Entz Werle, Claire Fieschi, Fanny Fouyssac, Pierre Frange, Vincent Gajdos, Lionel Galicier, Virginie Gandemer, Martine Gardembas, C. Gaud, B. Grosbois, Gaëlle Guillerm, É. Hachulla, Mohamed Hamidou, Sébastien Héritier, Olivier Hermine, C. Hoarau, Bruno Hoen, A. Hot, S. Humbert, Arnaud Jaccard, Serge Jacquot, Jean‐Philippe Jaïs, R. Jaussaud, Pierre‐Yves Jeandel, Éric Jeziorski, Kamila Kébaïli, Anne‐Sophie Korganow, Philippe Labrune, Olivier Lambotte, Fanny Lanternier, C. Larroche, Alain Le Quellec, Emmanuelle Le Moigne, Vincent Le Moing, Yvon Lebranchu, Marc Lecuit, Guillaume Lefèvre, Richard Lemal, Philippe Le Moine, Valérie Li Thiao Te, Olivier Lortholary, Patrick Lutz, Aude Magérus, Marion Malphettes, Aude Marie‐Cardine, Nicolas Martin Silva, A. Masseau, Christian Massot, Françoise Mazingue, Étienne Merlin, Gérard Michel, Frédéric Millot, Odile Minckes, Béatrice Monlibert, Fabrice Monpoux, Despina Moshous and 34 more - Journal of Allergy and Clinical Immunology 2017 cited by 317

  14. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis

    Authors: , , , , , , , , , , , , , , - Blood 2013 cited by 450

  15. Histiocytosis

    Authors: , , , , , , , , - The Lancet 2021 cited by 122

  16. A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Honghua Jiang, S.M. Li, Rick MacLeod, Murray Stewart, Arthur G. Taveras, Tina Z. Yan, Jean Donadieu - Blood 2024 cited by 52

  17. Somatic genetic alterations predict hematological progression in GATA2 deficiency

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Haematologica 2023 cited by 38

  18. Premature Ovarian Insufficiency in CLPB Deficiency: Transcriptomic, Proteomic and Phenotypic Insights

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2022 cited by 27

  19. Somatic genetic rescue of a germline ribosome assembly defect

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter J. Bond, Christine Bellanné‐Chantelot, Isabelle Callebaut, François Delhommeau, Jean Donadieu, Alan J. Warren, Patrick Revy - Nature Communications 2021 cited by 74

  20. Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work‐up, and treatment for patients till the age of 18 years

    Authors: , , , , , , , , , , , , , , - Pediatric Blood & Cancer 2012 cited by 686

  21. Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine Bellanné‐Chantelot, Marlène Pasquet - Haematologica 2018 cited by 178

  22. Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean‐François Emile, Khê Hoang‐Xuan, Ahmed Idbaïh, Jean Donadieu - British Journal of Haematology 2018 cited by 105

  23. Reproducible and Sustained Efficacy of Targeted Therapy With Vemurafenib in Patients With BRAFV600E-Mutated Erdheim-Chester Disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 cited by 287

  24. Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2014 cited by 255